DE60204232D1 - Antagonisten für calciumkanäle vom n-typ zur behandlung von schmerzen - Google Patents

Antagonisten für calciumkanäle vom n-typ zur behandlung von schmerzen

Info

Publication number
DE60204232D1
DE60204232D1 DE60204232T DE60204232T DE60204232D1 DE 60204232 D1 DE60204232 D1 DE 60204232D1 DE 60204232 T DE60204232 T DE 60204232T DE 60204232 T DE60204232 T DE 60204232T DE 60204232 D1 DE60204232 D1 DE 60204232D1
Authority
DE
Germany
Prior art keywords
sup
treatment
pain
antagonists
type calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60204232T
Other languages
English (en)
Other versions
DE60204232T2 (de
Inventor
Amico Derin D
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of DE60204232D1 publication Critical patent/DE60204232D1/de
Application granted granted Critical
Publication of DE60204232T2 publication Critical patent/DE60204232T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
DE60204232T 2001-08-27 2002-08-23 Antagonisten für calciumkanäle vom n-typ zur behandlung von schmerzen Expired - Fee Related DE60204232T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0102858A SE0102858D0 (sv) 2001-08-27 2001-08-27 N-type calcium channel antagonists for the treatment of pain
SE0102858 2001-08-27
PCT/SE2002/001521 WO2003018561A1 (en) 2001-08-27 2002-08-23 N-type calcium channel antagonists for the treatment of pain

Publications (2)

Publication Number Publication Date
DE60204232D1 true DE60204232D1 (de) 2005-06-23
DE60204232T2 DE60204232T2 (de) 2006-01-26

Family

ID=20285150

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60204232T Expired - Fee Related DE60204232T2 (de) 2001-08-27 2002-08-23 Antagonisten für calciumkanäle vom n-typ zur behandlung von schmerzen

Country Status (7)

Country Link
US (1) US7153865B2 (de)
EP (1) EP1430030B1 (de)
JP (1) JP2005508894A (de)
AT (1) ATE295837T1 (de)
DE (1) DE60204232T2 (de)
SE (1) SE0102858D0 (de)
WO (1) WO2003018561A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003055866A1 (en) * 2001-12-21 2003-07-10 Bayer Pharmaceuticals Corporation Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
US7223754B2 (en) 2003-03-10 2007-05-29 Dynogen Pharmaceuticals, Inc. Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower urinary tract and related disorders
MXPA05009722A (es) * 2003-03-10 2006-03-09 Schering Corp Inhibidores heterociclicos de cinasa: metodos de uso y sintesis.
US7084116B2 (en) 2003-03-10 2006-08-01 Dynogen Pharmaceuticals, Inc. Methods for treating lower urinary tract disorders and the related disorders vulvodynia and vulvar vestibulitis using Cav2.2 subunit calcium channel modulators
WO2005000285A2 (en) * 2003-06-13 2005-01-06 Dynogen Pharmaceuticals, Inc. METHODS OF TREATING NON-INFLAMMATORY GASTROINTESTINAL TRACT DISORDERS USING Cav2.2 SUBUNIT CALCIUM CHANNEL MODULATORS
US20060128702A1 (en) * 2004-11-23 2006-06-15 Manojit Pal Heterocyclic and bicyclic compounds, compositions and methods
SI1963280T1 (sl) 2005-12-22 2016-02-29 Newron Pharmaceuticals S.P.A. 2-feniletilamino derivati kot modulatorji kalcijevih in/ali natrijevih kanalčkov
EA018195B1 (ru) 2007-06-15 2013-06-28 Ньюрон Фармасьютикалс С.П.А. Замещенные 2-[2-(фенил)этиламино]алканамидные производные и применение указанных соединений в качестве модуляторов натриевых и/или кальциевых каналов
CA2780111A1 (en) 2009-11-07 2011-05-12 Merck Patent Gmbh Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors
EP2723710B1 (de) 2011-06-27 2016-08-10 Newron Pharmaceuticals S.p.A. Fluorierte arylalkylaminocarboxamidderivate
KR20210007046A (ko) * 2013-02-01 2021-01-19 웰스태트 테러퓨틱스 코포레이션 항염증, 항진균, 항기생충, 및 항암 활성을 갖는 아민 화합물
EP2968360B1 (de) 2013-03-14 2021-01-20 ConverGene LLC Chinolinon-derivate zur hemmung von bromdomänenhaltigen proteinen
ES2918589T3 (es) * 2015-11-25 2022-07-19 Convergene Llc Inhibidores de bromodomios BET bicíclicos y usos de los mismos
JP6965432B2 (ja) * 2017-08-29 2021-11-10 チュラポーン ファンデーション キノリンおよびナフチリジンの誘導体および組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1573186A (en) * 1977-09-14 1980-08-20 Wyeth John & Brother Ltd 4-aminoquinoline derivatives
AU4802500A (en) * 1999-04-26 2000-11-10 Neurogen Corporation 2-aminoquinolinecarboxamides: neurokinin receptor ligands

Also Published As

Publication number Publication date
SE0102858D0 (sv) 2001-08-27
US7153865B2 (en) 2006-12-26
DE60204232T2 (de) 2006-01-26
EP1430030A1 (de) 2004-06-23
JP2005508894A (ja) 2005-04-07
US20050131020A1 (en) 2005-06-16
EP1430030B1 (de) 2005-05-18
WO2003018561A1 (en) 2003-03-06
ATE295837T1 (de) 2005-06-15

Similar Documents

Publication Publication Date Title
ATE323693T1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
ATE295837T1 (de) Antagonisten für calciumkanäle vom n-typ zur behandlung von schmerzen
IS6658A (is) Ný efnasambönd
ATE455092T1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
BRPI0408782A (pt) inibidores cìclicos da proteìna tirosina cinase
DE59807405D1 (de) Acylsulfamoylbenzoesäureamide, diese enthaltende nutzpflanzenschützende mittel und verfahren zu ihrer herstellung
DE60321929D1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
DE60313597D1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
NO20023934D0 (no) Nye forbindelser
ES2190803T3 (es) Iminas ciclicas como pesticidas.
ES2190246T3 (es) Nuevos compuestos de tiazolopirimidina.
SE0302139D0 (sv) Novel compounds
ATE363290T1 (de) Cd40 antagonist zur behandlung von psoriasis
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
DE60313004D1 (de) Alpha-7-nikotinsäure-rezeptoragonisten und statine in kombination
SE0004054D0 (sv) N-type calcium channel antagonists for the treatment of pain
YU13301A (sh) Muskarinski agonisti i antagonisti
TR199700834T1 (xx) 1-Aril-2-Akilamino ethan bile�ikleri ve bunlar�n n�rokinin olarak �zellikle n�rokinin 1 has�mlar� olarak kullan�mlar�.
SE0101038D0 (sv) Novel compounds
DE50310579D1 (de) Furancarboxamide
SE0003476D0 (sv) Compounds
ATE240303T1 (de) 1,2,4-triazol-3-thion verbindungen
SE0303280D0 (sv) Novel compounds
DE69808475T2 (de) Aminosäurederivate zur behandlung von schlaganfall
DE60137534D1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee